ANI Pharmaceuticals, Inc.(ANIP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ANIP ANI Pharmaceuticals, Inc.

交易中 07-22 13:08:23 EDT

61.90

-0.29

-0.47%

最高62.50	最低61.06	成交量3.89万
今开62.50	昨收62.19	日振幅2.32%
总市值12.98亿	流通市值9.94亿	总股本2,097万
成交额239.27万	换手率0.24%	流通股本1,605万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ANIP","market":"US","secType":"STK","nameCN":"ANI Pharmaceuticals, Inc.","latestPrice":61.9,"timestamp":1721668099382,"preClose":62.19,"halted":0,"volume":38858,"delay":0,"floatShares":16052400,"shares":20972513,"eps":1.617296,"marketStatus":"交易中","marketStatusCode":2,"change":-0.29,"latestTime":"07-22 13:08:23 EDT","open":62.5,"high":62.5,"low":61.06,"amount":2392659.20094,"amplitude":0.023155,"askPrice":62.04,"askSize":200,"bidPrice":61.77,"bidSize":20,"shortable":3,"etf":0,"ttmEps":1.617296,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1721678400000},"adr":0,"listingDate":1064980800000,"adjPreClose":62.19,"adrRate":0,"postHourTrading":{"tag":"盘后","latestPrice":62.19,"preClose":62.19,"latestTime":"16:03 EDT","volume":2267,"amount":140984.48,"timestamp":1721419383326},"volumeRatio":0.382768,"impliedVol":0.4361,"impliedVolPercentile":0.5538},"requestUrl":"/m/hq/s/ANIP","defaultTab":"news","newsList":[{"id":"2446004826","title":"BUZZ-因 ANI 制药公司被收购，Alimera 科学公司股价大涨近 80","url":"https://stock-news.laohu8.com/highlight/detail?id=2446004826","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2446004826?lang=zh_cn&edition=full","pubTime":"2024-06-25 00:40","pubTimestamp":1719247214,"startTime":"0","endTime":"0","summary":"    6月24日 - ** ANI Pharmaceuticals   提出收购要约后，眼药开发商Alimera Sciences   的股价周一飙升79.3%，达到5.65美元。** ALIM创2022年10月以来新高。2024 年股价将上涨约 11%，目前市值约为 13 亿美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BUZZ","ANIP","ALIM","BK4007"],"gpt_icon":0},{"id":"2445075618","title":"Alimera Sciences(ALIM.US)盘前暴涨超76%！获ANI Pharmaceuticals(ANIP.US)收购 估值3.81亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2445075618","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2445075618?lang=zh_cn&edition=full","pubTime":"2024-06-24 20:16","pubTimestamp":1719231368,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，ANI Pharmaceuticals宣布，将以每股5.50美元的价格现金收购Alimera Sciences。受此消息提振，截至发稿，Alimera Sciences周一美股盘前涨超76%。ANI Pharmaceuticals表示，此次收购将进一步推动其罕见病业务，并预计该交易将在2025年实现调整后NON-GAAP每股收益的高个位数至低两位数增长，且此后将实现大幅增长。ANI Pharmaceuticals计划使用手头现金和债务融资相结合的方式为此次交易融资。资料显示，ANI Pharmaceuticals开发、制造和销售仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1139706.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["ALIM","BK4007","ANIP"],"gpt_icon":0},{"id":"2417176870","title":"美国研究综述-CommScope Holding Company、Dutch Bros、Hess","url":"https://stock-news.laohu8.com/highlight/detail?id=2417176870","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2417176870?lang=zh_cn&edition=full","pubTime":"2024-03-05 03:21","pubTimestamp":1709580103,"startTime":"0","endTime":"0","summary":"    路透社3月4日 - 华尔街证券分析师周一调整了对几家美国上市公司的评级和目标价，其中包括 CommScope Holding Company、Dutch Bros 和 Hess。要点 * CommScope Holding Company   ：摩根大通将其股票评级从中性下调至减持  * 荷兰兄弟  ：Piper Sandler 将其评级从中性上调至增持  * Hess Corp   ：Susquehanna 将目标价从 152 美元上调至 156 美元  * Pioneer Natural Resources Co   ：苏斯克汉纳将目标价从237美元上调至246美元  * United Therapeutics Corp   ：摩根大通将目标价从294美元下调至280美元  以下是路透社周一报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AAPL","BRFS","ARIS","BALL","LU0979878070.USD","IE00BMPRXR70.SGD","AVGO","ACRE","AMD","BP","BLK","AHR","ABEV","BXMT","APG","IE00B894F039.SGD","AI","LU1814569148.SGD","BK4129","AEMD","AKRO","BBIO","APA","BRP","BBWI","RNAC","CELH","AZEK","AMPH","ANNX","COF","AVDX","BRSP","AMRC","BK4110","ANIP","CHE","LU0234572021.USD","BROS","BK4535","CHK","IE00BZ1G4Q59.USD","BV","GTLS","ARI","APLS","LU0965509283.SGD","AR","AHCO","BHVN"],"gpt_icon":0},{"id":"2416696524","title":"Ani Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2416696524","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2416696524?lang=zh_cn&edition=full","pubTime":"2024-02-29 22:32","pubTimestamp":1709217144,"startTime":"0","endTime":"0","summary":"北京时间2024年02月29日22时32分，Ani Pharmaceuticals, Inc.股票出现异动，股价快速上涨5.88%。截至发稿，该股报63.83美元/股，成交量1.0505万股，换手率0.05%，振幅1.29%。Ani Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.62%。其相关个股中，Societal Cdmo, Inc.、大自然药业、阿索尔达生物涨幅较大，Societal Cdmo, Inc.、Petros Pharmaceuticals, Inc.、Ironwood医药较为活跃，换手率分别为4.11%、3.05%、1.86%，振幅较大的相关个股有Neptune Wellness Solutions Inc.、Amphastar Pharmaceuticals, Inc.、阿玛琳，振幅分别为12.27%、10.55%、9.09%。Ani Pharmaceuticals, Inc.公司简介：ANI Pharmaceuticals Inc 开发、制造和销售仿制药。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922322487d23f27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024022922322487d23f27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ANIP","BK4007"],"gpt_icon":0},{"id":"2411686106","title":"美国研究综述-阿尔伯马尔、Dropbox、英伟达","url":"https://stock-news.laohu8.com/highlight/detail?id=2411686106","media":"Reuters","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2411686106?lang=zh_cn&edition=full","pubTime":"2024-02-16 21:53","pubTimestamp":1708091615,"startTime":"0","endTime":"0","summary":"    路透社2月16日 - 华尔街证券分析师周五调整了对几家美国上市公司的评级和目标价，包括 Albemarle、Dropbox 和 Nvidia。要闻 * Albemarle Corp   ：摩根大通将目标价从130美元下调至115美元  * Bloom Energy Corp   ：KeyBanc将其评级从 \"增持 \"下调至 \"行业权重\"。* Dropbox Inc   ：摩根大通将其评级从 \"增持 \"下调至 \"中性\"。* Nvidia Corp   ：奥本海默将目标价从650美元上调至850美元  * Tyler Technologies Inc   ：Piper Sandler将目标价从480美元上调至520美元  以下是路透社周五报道的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CBT","LU0208291251.USD","ANAB","AORT","BHVN","BPMC","CALC","CMBM","BHF","IE00BFSS8Q28.SGD","IE00BJJMRX11.SGD","BK4548","AGIO","LU0316494557.USD","ANGI","BLZE","AR","BE","LU0820562030.AUD","FUN","CBRE","BXMT","BJRI","ALNY","ANIP","ATRC","LU2065171311.SGD","CF","ANGO","LU2249611893.SGD","CDRE","AIG","AEL","APLE","ARCH","NVDA","TXG","CVNA","BWA","CWST","HOUS","AMAT","APD","BK4090","LU1815336760.USD","ALB","AWK","CACI","LU0109391861.USD","BIO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.anipharmaceuticals.com","stockEarnings":[{"period":"1week","weight":-0.0206},{"period":"1month","weight":0.0239},{"period":"3month","weight":-0.0502},{"period":"6month","weight":0.1224},{"period":"1year","weight":0.2034},{"period":"ytd","weight":0.1279}],"compareEarnings":[{"period":"1week","weight":-0.0196},{"period":"1month","weight":0.0009},{"period":"3month","weight":0.1087},{"period":"6month","weight":0.138},{"period":"1year","weight":0.2141},{"period":"ytd","weight":0.155}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"ANI Pharmaceuticals, Inc.于2001年4月成立于特拉华州。该公司是一家综合性的特种制药公司，致力于通过开发，制造和销售高质量的品牌和通用处方药来为公司的客户提供价值。 该公司专注于利基和高入口机会，包括受控物质，抗癌（溶瘤药），激素和类固醇，以及复杂的制剂。 该公司位于明尼苏达州Baudette的两家制药厂能够生产口服固体剂量产品，以及液体和局部，受控物质和必须在完全封闭的环境中制造的有效产品。 该公司的战略是使用其资产开发，收购，制造和销售品牌和通用专业处方药。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.064659},{"month":2,"riseRate":0.416667,"avgChangeRate":0.0136},{"month":3,"riseRate":0.375,"avgChangeRate":-0.029311},{"month":4,"riseRate":0.541667,"avgChangeRate":0.137911},{"month":5,"riseRate":0.416667,"avgChangeRate":-0.019321},{"month":6,"riseRate":0.64,"avgChangeRate":0.036553},{"month":7,"riseRate":0.4,"avgChangeRate":-0.038885},{"month":8,"riseRate":0.458333,"avgChangeRate":-0.009748},{"month":9,"riseRate":0.458333,"avgChangeRate":0.027611},{"month":10,"riseRate":0.5,"avgChangeRate":-0.034817},{"month":11,"riseRate":0.625,"avgChangeRate":0.088953},{"month":12,"riseRate":0.458333,"avgChangeRate":-0.053943}],"exchange":"NASDAQ","name":"ANI Pharmaceuticals, Inc.","nameEN":"ANI Pharmaceuticals"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ANI Pharmaceuticals, Inc.(ANIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ANI Pharmaceuticals, Inc.(ANIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ANI Pharmaceuticals, Inc.,ANIP,ANI Pharmaceuticals, Inc.股票,ANI Pharmaceuticals, Inc.股票老虎,ANI Pharmaceuticals, Inc.股票老虎国际,ANI Pharmaceuticals, Inc.行情,ANI Pharmaceuticals, Inc.股票行情,ANI Pharmaceuticals, Inc.股价,ANI Pharmaceuticals, Inc.股市,ANI Pharmaceuticals, Inc.股票价格,ANI Pharmaceuticals, Inc.股票交易,ANI Pharmaceuticals, Inc.股票购买,ANI Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ANI Pharmaceuticals, Inc.(ANIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ANI Pharmaceuticals, Inc.(ANIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}